Terumo Blood and Cell Technologies is aware of the BadAlloc global cybersecurity vulnerabilities. Our internal teams are performing technical product assessments to determine any potential risks. We actively monitor our company’s internal Internet-connected devices, as well as the broader industry for other possible cybersecurity vulnerabilities. Terumo Blood and Cell Technologies recommends that everyone in the global healthcare ecosystem employ industry standard network security management and monitoring of their environments. Additional information will be posted on this page as it becomes available.